| Meet the Professor |
07:30-08:20, Crystall Ballroom A,B,C |
| 1:Acquired resistance to EGFR or ALK TKI |
| Tetsuya Mitsudomi (Kinki University, Japan) |
| 2:Clinical application of next generation sequencing |
| Woong-Yang Park (Samsung Genome Institute, Samsung Medical Center) |
|
| Plenary Session (in English) |
08:30~09:30, Crystall Ballroom |
| 1) Does the patient subset with high tumor Carbonic anhydrase 9 (CA9) expression benefit from prophylactic irradiation of para-aortic lymph nodes?: a randomized, open-label, multicenter, phase II trial KROG 07-01 for locally advanced uterine cervical cancer
|
| Joo-Young Kim (National Cancer Center) |
| 2) Comparison of concurrent chemoradiation therapy with three weekly versus weekly
cisplatin in patients with locally advanced nasopharyngeal cancer:
a multicenter randomized phase II non-inferiority trial (KCSG-HN10-02) |
| Ji Yun Lee (Samsung Medical Center) |
| 3) A Dual Role of miR-155 in mouse Breast Cancer Model |
| Suhwan Chang (Asan Medical Center) |
|
| Special Lecture (in English) |
09:30~10:00, Crystal Ballroom |
| Living the American dream : an exciting journey of opportunities and challenges |
|
| Waun Ki Hong, M.D., F.A.C.P., D.M.Sc.(Hon.) (The University of Texas M.D. Anderson Cancer Center, USA)
|
|
| Plenary Lecture 3 (in English) |
10:20~10:50, Crystal Ballroom |
| The advent of multidisciplinary health care beyond the multidisciplinary treatment against gastric cancer |
| Sung Hoon Noh, M.D., Ph.D., FACS. (Yonsei University College of Medicine) |
|
| Plenary Lecture 4 (in English) |
10:50~11:40, Crystal Ballroom |
| Genomically guided radiation therapy |
| Javier F. Torres-Roca, MD (Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, USA) |
|
| Symposium 10 |
13:40~15:20, Crystal Ballroom A |
| Joint Symposium (Korean Cancer Association & Korean Society of Coloproctology) |
| I. Surgical advances in colorectal cancer |
| 1) Concept of CME |
| Seung Hyuk Baik (Yonsei University College of Medicine) |
| 2) CCR after preop CCRT, what are the current options? |
| Jung Wook Huh (Samsung Medical Center) |
| 3) Role of palliative surgery in incurable stage IV colorectal cancer |
| Seung-Kook Sohn (Yonsei University College of Medicine) |
|
| II. Medico-RT issues |
| 1) Recent update in chemotherapy for colorectal cancer |
| Yong Sang Hong (Asan Medical Center) |
| 2) Recent update in radiotherapy for stage II-III rectal cancer |
| Hong Seok Jang (The Catholic University of Korea College of Medicine) |
|
| Symposium 11 (in English) |
13:40~15:20, Crystal Ballroom B |
| Joint Symposium (Korean Cancer Association & The Korean Society for Pediatric Neuro-Oncology) |
| Optimal management of pediatric CNS germ cell tumor |
| 1) Role of Surgery in CNS GCT |
| Tai-Tong Wong (Cheng Hsin Hosptial, Taiwan) |
| 2) Radiation therapy for CNS germinoma |
| Yuta Shibamoto (Nagoya City University, Japan) |
| 3) Update of Chemotherapy |
| Chuhl Joo Lyu (Yonsei University College of Medicine) |
|
| Symposium 12 (in English) |
13:40~15:20, Crystal Ballroom C |
| Evolution and revolution of lung cancer treatment |
| 1) Spatial and temporal Heterogeneities of lung cancer |
| Tetsuya Mitsudomi (Kinki University, Japan) |
| 2) Evolution and future of immunotherapy in lung cancer |
| Ji-Youn Han (National Cancer Center) |
| 3) High precision radiotherapy of lung cancer |
| Hong-Ryull Pyo (Samsung Medical Center) |
| 4) Changing role of surgery in oligometastatic lung cancer |
| Young Tae Kim (Seoul National University College of Medicine) |
|
| Symposium 13 |
13:40~15:20, Sapphire Ballroom A |
| Joint Symposium (Korean Cancer Association & Korean Society of Gynecologic Oncology) |
| I. An updated review of current clinical trials in gynecologic cancer
|
| 1) Updated review of current clinical trials in cervical cancer |
| Sang Young Ryu (Korea Institute of Radiological & Medical Sciences) |
| 2) An updated review of current clinical trials in ovarian cancer |
| Jae-Weon Kim (Seoul National University College of Medicine) |
| 3) An updated review of current clinical trials in endometrial cancer |
| Seok Ju Seong (CHA University College of Medicine) |
|
| II. New researches in gynecologic cancer |
| 1) Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in
CIN3 patients |
| Tae Jin Kim (Dankook University College of Medicine) |
| 2) Prevalence study of BRCA mutation in Korean women with ovarian cancer |
| Jeong-Won Lee (Samsung Medical Center) |
| 3) Detecting circulating tumor DNA in ovarian cancer |
| Shin-Wha Lee (Asan Medical Center) |
|
| Symposium 14 (in English) |
13:40~15:20, Sapphire Ballroom B |
| Cancer panel |
| 1) Find a needle in a haystack: A nation-wide genome screening program for lung and colorectal cancer patients, SCRUM-Japan |
| Katsuya Tsuchihara (National Cancer Center, Japan) |
| 2) Clinical application of actionable cancer genome analysis for precision oncology |
| Woong-Yang Park (Samsung Genome Institute, Samsung Medical Center) |
| 3) NGS-based Korean pan-cancer companion diagnostics for targeted therapeutics |
| Ju Han Kim (Seoul National University College of Medicine) |
| 4) Application of cancer panel for studying the progression of cancers |
| Yeun-Jun Chung (The Catholic University of Korea College of Medicine) |
|
| Symposium 15 (in English) |
15:40~17:20, Crystal Ballroom A |
| Druggable oncogenic pathway |
| 1) Development of ramucirumab in gastric and gastroesophageal cancers
|
| David Ferry (Eli Lilly, USA) |
| 2) Immune checkpoints for cancer treatment |
| Florin Sirzen (Roche, Switzerland) |
| 3) MEDI4736 (anti-PDL1): an overview of global development as monotherapy and in combination |
| Aiman Shalabi (Astrazeneca, USA) |
| 4) AZD9291: an overview of global development of a T790M directed EGFR-TKI
|
| Younghwa Kim (Astrazeneca, Korea) |
|
| Symposium 16 (in English) |
15:40~17:20, Crystal Ballroom C |
| Cancer stem cell |
| 1) LMO2 regulates tumorigenic and angiogenic traits in cancer stem cells |
| Hyunggee Kim (Korea University School of Life Sciences & Biotechnology) |
| 2) Cross-talk between the Wnt/©¬-catenin and Ras pathways in the tumor growth and metastasis involving cancer stem cell activation |
| Kang-Yell Choi (Yonsei University College of Life Science and Biotechnology) |
| 3) EGFRvIII promotes self-renewal of infiltrating glioma stem cells via PEDF secretion |
| Jong Bae Park (National Cancer Center) |
| 4) Personalized targeted therapy based on AVATAR Mouse® & AVATASCAN® |
| Do-Hyun Nam (Samsung Medical Center) |
|
| Satellite Symposium 5 (in English) |
12:00~12:50, Crystal Ballroom |
| Immunology translational research and Immune check point inhibitors in solid tumors (by ONO Pharma and BMS)
|
| Jonathan Simon Cebon (Medicine at the University of Melbourne & Royal Australasian College of Physicians, Australia) |
|
| Satellite Symposium 6 (in English) |
12:00~12:50, Sapphire Ballroom |
| Emerging standard of treatment in 2nd line advanced gastric cancer (by Lilly) |
| Se-Hoon Park (Samsung Medical Center) |
|
|
| Oral Presentation 6 |
15:40~16:30, Crystall Ballroom B |
|
| Oral Presentation 7 |
16:30~17:20, Crystall Ballroom B |
|
| Oral Presentation 8 |
15:40~16:30, Sapphire Ballroom A |
|
| Oral Presentation 9 |
16:30~17:20, Sapphire Ballroom A |
|
| International Session 3 (Oral, in English) |
15:40-16:30, Sapphire Ballroom B |
|
| International Session 4 (Oral, in English) |
16:30-17:20, Sapphire Ballroom B |
|
| Poster Presentation |
09:00~17:00, Emerald Room |
|
